TY - JOUR
T1 - Increasing hepatitis b screening for hmong adults
T2 - Results from a randomized controlled community-based study
AU - Chen, Moon S.
AU - Fang, Dao M.
AU - Stewart, Susan L.
AU - Ly, May Ying
AU - Lee, Serge
AU - Dang, Julie H T
AU - Nguyen, Tram T.
AU - Maxwell, Annette E.
AU - Bowlus, Christopher L.
AU - Bastani, Roshan
AU - Nguyen, Tung T.
PY - 2013/5
Y1 - 2013/5
N2 - Background: Hepatitis B-linked liver cancer disproportionately affects Hmong Americans. With an incidence rate of 18.9 per 100,000, Hmong Americans experience liver cancer at a rate that is 6 to 7 times more than that of non-Hispanic Whites. Serologic testing for the hepatitis B virus (HBV) is a principal means to prevent liver cancer-related deaths through earlier identification of those at risk. Methods: Academic researchers andHmongleaders collaborated in the design, conduct, and evaluation of a 5-year randomized controlled trial testing a lay health worker (LHW) intervention to promote HBV testing among 260 Hmong adults through in-home education and patient navigation. Results: Intervention group participants were more likely to report receiving serologic testing for HBV (24% vs. 10%, P=0.0056) and showed a greater mean increase in knowledge score (1.3 vs. 0.3 points, P=0.0003) than control group participants. Multivariable modeling indicated that self-reported test receipt was associated with intervention group assignment [OR 3.5; 95% confidence interval (CI) 1.3-9.2], improvement in knowledge score (OR 1.3 per point; 95% CI 1.02-1.7), female gender (OR 5.3; 95% CI 1.7-16.6), and having seen a doctor in the past year at baseline (OR 4.8; 95% CI 1.3-17.6). The most often cited reason for testing was a doctor's recommendation. Conclusions:LHWswere effective in bringing aboutHBVscreening. Doctor visits and adherence to doctors' recommendations were pivotal. Participation of health care providers is essential to increase HBV testing. Impact:LHWscan significantly increaseHBVscreening rates forHmongbut their doctors' recommendation is highly influential and should be pursued. Cancer Epidemiol Biomarkers Prev; 22(5); 782-91.
AB - Background: Hepatitis B-linked liver cancer disproportionately affects Hmong Americans. With an incidence rate of 18.9 per 100,000, Hmong Americans experience liver cancer at a rate that is 6 to 7 times more than that of non-Hispanic Whites. Serologic testing for the hepatitis B virus (HBV) is a principal means to prevent liver cancer-related deaths through earlier identification of those at risk. Methods: Academic researchers andHmongleaders collaborated in the design, conduct, and evaluation of a 5-year randomized controlled trial testing a lay health worker (LHW) intervention to promote HBV testing among 260 Hmong adults through in-home education and patient navigation. Results: Intervention group participants were more likely to report receiving serologic testing for HBV (24% vs. 10%, P=0.0056) and showed a greater mean increase in knowledge score (1.3 vs. 0.3 points, P=0.0003) than control group participants. Multivariable modeling indicated that self-reported test receipt was associated with intervention group assignment [OR 3.5; 95% confidence interval (CI) 1.3-9.2], improvement in knowledge score (OR 1.3 per point; 95% CI 1.02-1.7), female gender (OR 5.3; 95% CI 1.7-16.6), and having seen a doctor in the past year at baseline (OR 4.8; 95% CI 1.3-17.6). The most often cited reason for testing was a doctor's recommendation. Conclusions:LHWswere effective in bringing aboutHBVscreening. Doctor visits and adherence to doctors' recommendations were pivotal. Participation of health care providers is essential to increase HBV testing. Impact:LHWscan significantly increaseHBVscreening rates forHmongbut their doctors' recommendation is highly influential and should be pursued. Cancer Epidemiol Biomarkers Prev; 22(5); 782-91.
UR - http://www.scopus.com/inward/record.url?scp=84877944450&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877944450&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-12-1399
DO - 10.1158/1055-9965.EPI-12-1399
M3 - Article
C2 - 23613027
AN - SCOPUS:84877944450
VL - 22
SP - 782
EP - 791
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
SN - 1055-9965
IS - 5
ER -